Latest Melphalan Stories
Single-center, retrospective study evaluates Hepatic Progression Free Survival and Overall Survival after Regional Therapy NEW YORK, March 27, 2015 /PRNewswire/ -- Delcath Systems,
NEW YORK, March 9, 2015 /PRNewswire/ -- Delcath Systems, Inc.
NEW YORK, March 3, 2015 /PRNewswire/ -- Delcath Systems, Inc.
NEW YORK, March 2, 2015 /PRNewswire/ -- Delcath Systems, Inc.
NEW YORK, Oct. 14 /PRNewswire/ -- Delcath Systems, Inc.
CHICAGO, June 5 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented data showing that by combining two treatment agents in the care of multiple myeloma patients, doctors can use higher dosages of chemotherapy before autologous stem cell transplant while alleviating painful and debilitating side effects like severe oral mucositis (mouth ulcers).
SAN FRANCISCO, Dec.
The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy, and support for myeloma patients, families, researchers, and physicians - today heralded the expansion of treatment options for previously untreated patients with multiple myeloma, giving patients in Canada and Europe access to drugs similar to what is available to patients in the United States.
- To play, gamble.
- To impose upon; delude; trick; humbug; also, to joke; chaff.
- A deceitful game or trick; trickery; humbug; nonsense.